Stock listing
CELU Stock Price, News, Filings & Events — Celularity Inc.
Selected listing: CELU · NASDAQ · USD · US
This page tracks Celularity Inc.'s CELU:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CELU:NASDAQ. CELU:NASDAQ is the stock-level entry point for investors researching Celularity Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Celularity Inc. is a public company listed under the ticker CELU, operating in the American market. The company has a market capitalization of approximately $21.7 million. Celularity focuses on innovative cell therapies and regenerative medicine solutions.
- Ticker
- CELU:NASDAQ
- Asset type
- Stock
- Market cap
- $40.8M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- NASDAQ
- Currency
- USD
Celularity Inc. CELU:NASDAQ stock context
This page tracks Celularity Inc.'s CELU:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CELU:NASDAQ. CELU:NASDAQ is the stock-level entry point for investors researching Celularity Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Celularity Inc. is a public company listed under the ticker CELU, operating in the American market. The company has a market capitalization of approximately $21.7 million. Celularity focuses on innovative cell therapies and regenerative medicine solutions.
Latest news from Celularity Inc.
Celularity and MuseCell Innovations® Announce U.S. Manufacturing Collaboration for the Dezawa MuseCell® Platform
August 27, 2026
Celularity Provides Update Regarding Nasdaq Listing Compliance
August 25, 2026
Celularity and Fountain Life Announce Availability of Cenplacel-L for Investigational Use Under New Florida Law, Establishing Scalable Pathway for Advancement of Placental-Derived Cell Therapies
June 4, 2026
Celularity Appoints Rick Gonzalez as Chief Commercial Officer
June 3, 2026
Celularity Announces Filing of Form 10-K, Regains Nasdaq Compliance and Highlights Continued Strategic Transformation
May 1, 2026
Research Celularity Inc.
Celularity Inc. investor report
Review AI stock analysis and investor report context for CELU:NASDAQ.
Celularity Inc. company profile
View the public company page for Celularity Inc. on 6ix.
Celularity Inc. news
Read company news and market updates connected to Celularity Inc..
Celularity Inc. investor events
Find investor webinars, events, and replay context for Celularity Inc..